| SCHEDULE OF DILUTIVE SECURITIES |
The
following securities were excluded from the computation of diluted loss per share because their effect would have been anti-dilutive:
SCHEDULE
OF DILUTIVE SECURITIES
| | |
June 30, 2026 | | |
June 30, 2025 | |
|
June 30, 2026 |
|
|
June 30, 2025
|
|
| | |
Three Months Ended June 30, | |
|
Six Months Ended June 30,
|
|
| | |
June 30, 2026 | | |
June 30, 2025 | |
|
June 30, 2026 |
|
|
June 30, 2025
|
|
| Convertible notes payable (1) | |
| 16,090,884 | | |
| 704,272 | |
|
|
16,090,884 |
|
|
|
704,272 |
|
| Warrants | |
| - | | |
| 4,504 | |
|
|
- |
|
|
|
11,137 |
|
| Stock options | |
| - | | |
| 177,485 | |
|
|
- |
|
|
|
193,721 |
|
| Restricted stock units | |
| 170,604 | | |
| - | |
|
|
1,040,726 |
|
|
|
- |
|
| Total excluded shares | |
| 16,261,488 | | |
| 886,261 | |
|
|
17,131,610 |
|
|
|
909,130 |
|
| (1) |
|
Amount
assumes conversion of convertible notes payable outstanding principal and interest as of June 30, 2026 and 2025, using the conversion price
calculated from the minimum 10-day volume weighted average price at June 30, 2026 and 2025, respectively. |
|